Indo Borax Pledges 14% Stake in Kronox Lab Sciences for ₹225 Crore Loan
Indo Borax & Chemicals Ltd · Others (Uncategorized) · 19 Oct 2026, 9:21 pm
Indo Borax Pledges 14% Stake in Kronox Lab Sciences for ₹225 Crore Loan Indo Borax & Chemicals Ltd. created a pledge on 19th Oct'26 over 51,94,560 equity shares of its subsidiary, Kronox Lab Sciences Ltd., representing ~14% of Kronox's paid-up equity capital. The pledge serves as security for a ₹225 crore term loan facility availed to finance the acquisition of Kronox shares. Indo Borax currently holds 2,38,44,000 shares, or 64.26%, in Kronox. The transaction results in no change in shareholding or management control, with Kronox remaining a subsidiary.
Original exchange filing (PDF)
More announcements from Indo Borax & Chemicals Ltd
- Creation of further pledge over equity shares of Kronox Lab Sciences Limited. · 18 Nov 2026
- Pursuant to regulation 30 of the Securities Exchange Borad of India (LODR) Regulations, 2015, please find enclosed herewith the press release on un-audited financial results for the quarter .... · 11 Nov 2026
- Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026. · 06 Nov 2026
- Indo Borax & Chemicals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 06 Nov 2026
- Disclosure under Regulation 30 of the SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015 - Updation regarding Creation of pledge over equity shares held in Kronox .... · 04 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters · 06 Nov 2026
- INDO BORAX & CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 06-Nov-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 06 Nov 2026
- Indo Borax & Chemicals Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve the Unaudited Financial .... · 06 Nov 2026
